Publisher
Springer Science and Business Media LLC
Reference31 articles.
1. U.S. Food and Drug Administration. Clinical outcome assessment (COA): frequently asked questions 2020. Available from https://www.fda.gov/about-fda/clinical-outcome-assessment-coa-frequently-asked-questions#COADefinition. Accessed 31 Oct 2023.
2. Haywood KL, de Wit M, Staniszewska S, Morel T, Salek S. Developing patient-reported and relevant outcome measures. In: Facey KM, Ploug Hansen H, Single ANV, editors. Patient involvement in health technology assessment. Singapore: Springer Singapore; 2017. p. 103–20.
3. Acquadro C, Berzon R, Dubois D, Leidy NK, Marquis P, Revicki D, et al. Incorporating the patient’s perspective into drug development and communication: an ad hoc task force report of the patient-reported outcomes (PRO) harmonization group meeting at the food and drug administration, February 16, 2001. Value Health. 2003;6(5):522–31.
4. U.S. Food and Drug Administration. Patient-reported outcome measures: use in medical product development to support labeling claims 2009. Available from https://www.fda.gov/regulatory-information/search-fda-guidance-documents/patient-reported-outcome-measures-use-medical-product-development-support-labeling-claims. Accessed 31 Oct 2023.
5. Greenhalgh J. The applications of PROs in clinical practice: what are they, do they work, and why? Qual Life Res. 2009;18(1):115–23.